TB500 (Thymosin Beta) – 2mg

TB-500 (Thymosin Beta-4) 2mg protocols focus on this synthetic peptide fragment of the naturally occurring thymosin beta-4 protein, studied for its potential role in tissue repair, inflammation modulation, and recovery acceleration. TB-500 is commonly used in research settings involving muscle, tendon, ligament, and soft tissue healing. This guide outlines a subcutaneous administration approach optimized for the 2 mg vial format.

  • Reconstitute: Add 1.0 mL bacteriostatic water → 2 mg/mL concentration
  • Typical dosing range: 2–5 mg per week (split into multiple doses)
  • Easy measuring: At 2 mg/mL, 1 unit = 0.01 mL = 20 mcg (0.02 mg) on a U-100 insulin syringe
  • Storage: Lyophilized: store at −20 °C; after reconstitution, refrigerate at 2–8 °C and use within 2–4 weeks

Concise summary of the subcutaneous regimen.

  • Goal: Support tissue repair, reduce inflammation, and enhance recovery
  • Schedule: 2–3 injections per week or a short daily loading phase followed by maintenance
  • Dose Range: 2–5 mg per week total

Suggested approach for the 2 mg vial format.

  • Start: 0.5–1 mg 2–3 times per week
  • Loading phase (optional): 2 mg twice weekly or smaller daily doses for 1–2 weeks
  • Maintenance: 2–5 mg per week, depending on recovery needs
  • Frequency: 2–3 injections weekly (subcutaneous)
  • Vial Duration: One 2 mg vial typically lasts 1–4 days, depending on protocol style
  • Timing: Flexible; often used near injury sites or systemic subcutaneous sites

TB-500 (Thymosin Beta-4) is a synthetic version of a naturally occurring peptide involved in cellular repair and regeneration. It plays a key role in actin regulation, which is essential for cell structure, movement, and tissue remodeling.

By influencing actin polymerization and cell migration, TB-500 may support the formation of new blood vessels (angiogenesis), reduce inflammatory signaling, and enhance tissue repair processes. Preclinical studies suggest it may accelerate healing in muscles, tendons, ligaments, skin, and other soft tissues, particularly in injury or high-stress conditions.

Observations based on preclinical and early research use.

Potential Benefits:

  • May support faster recovery from injuries
  • May improve flexibility and reduce stiffness
  • May promote tissue repair and regeneration
  • May reduce inflammation in soft tissues

Possible Side Effects:

  • Mild fatigue or temporary lethargy in some cases
  • Injection-site irritation
  • Headache or dizziness (rare)
  • Long-term human safety data are limited; it remains investigational